02:00 PM EST, 12/20/2024 (MT Newswires) -- Aptose Biosciences ( APTO ) shares gained 51% amid heavy trading after the firm said overnight a Nasdaq hearings panel approved its request for an extension to prove compliance with the exchange's listing requirements.

More than 289.8 million shares traded intraday compared with a daily average of about 1.2 million.

Humacyte ( HUMA ) said late Thursday the US Food and Drug Administration granted full approval for SYMVESS, a bioengineered human tissue designed to be universally implantable.

Shares rose 32% as intraday trading volume grew to more than 64.3 million from a daily average of about 3.11 million.

Taoping ( TAOP ) said Friday that the Nasdaq Stock Market confirmed the company was granted an additional 180 calendar days to comply with its minimum bid price requirement through June 16.

Shares increased 29%, with intraday trading volume at over 134.5 million compared with a daily average of about 739,000.

Price: 0.26, Change: +0.09, Percent Change: +51.41